PROTEINA

Owners

Goods & Services

Medical analysis for the diagnosis and treatment of persons; Medical analysis services for cancer diagnosis and prognosis; Provision of information regarding cancer prevention, screening, diagnosis, and treatment; Medical analysis services relating to cancer diagnoses; Analysis of human biometric data for medical purposes; Medical analysis services relevant to diagnoses; Medical information services relating to pharmaceuticals and medical products; Providing information services relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals for pharmaceuticals and medical products; Medical diagnostic services for testing and analysis; Analysis of human tissue for medical treatment; Medical testing for diagnostic or treatment purposes; Medical testing services relating to the diagnosis and treatment of disease; Clinical medical consultation services, namely, collecting, reviewing, analyzing, and reporting clinical data; Medical analysis services relating to treatment of patients

Conducting early evaluation of new pharmaceutical compounds in development by others; Discovery and development of new drug candidate material; Scientific research for medical purposes in the area of cancerous diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical product evaluation, namely, technical assessment of the efficiency of pharmaceuticals; Medical research laboratory services for predicting disease; Pharmaceutical testing; Pharmaceutical research services; Provision of information regarding testing, inspection, and research of pharmaceutical products; Pharmaceutical product evaluation; Scientific research into medicine, health, and pharmacology; Human tissue analysis for the purpose of medical research; Design of devices intended for protein analysis; Protein analysis; Development of devices intended for protein analysis; Scientific and technological services, namely, scientific research in the field of biopharmaceuticals; Development of medical diagnostic instruments; Technological research in the field of biopharmaceuticals; Technical data analysis services for genomic and proteomic materials; Materials analysis; Development of computer software for big data processing; Biomedical research services; Biological research; Pharmaceutical research and development; Medical and scientific research, namely, conducting clinical trials by proxy; Medical and scientific research, namely, conducting clinical studies of medicines for others; Pharmaceutical product evaluation; Scientific research services for medical purposes; Design of medical diagnostic apparatus and instruments; Development of computer software for use with medical equipment; Laboratory research services relating to pharmaceuticals; Design and development of image processing software; Medical analysis services relevant to drug development, laboratory testing, and scientific research; Providing medical and scientific research information services relating to pharmaceuticals and medical products in the fields of pharmaceuticals and genetics; Medical laboratory services for the analysis of samples taken from patients

Biochip for research or scientific purposes; Biochip analyzing apparatus, namely, optical imaging apparatus and instruments in conjunction with biochip for use in the study of proteins, peptides, DNA, aptamer, and RNA, not for medical purposes; Biochip sensors for research or scientific purposes; Cell chip inspection devices, namely, bio-cell chips for research or scientific purposes; Diagnostic apparatus for the detection of biomarkers for laboratory or research use; Protein analysis devices, namely, scientific apparatus and instruments for analyzing protein; Laboratory apparatus for analyzing biological pharmaceuticals; Scientific instruments for analyzing chemical and biological substances for the presence, absence, or quantity of target biologics and chemicals; Optical imaging apparatus and instruments for use in the study of proteins, peptides, DNA, aptamer, and RNA, not for medical purposes; Biosensors, namely, sensors for the purpose of scientific and diagnostic use for detecting the presence of multiple molecular substances; Diagnostic apparatus for the detection of proteins, DNA, and cells, not for medical purpose; Downloadable and recorded computer software for use in database generation, analysis, and management; Downloadable and recorded computer software for use in optical image and scientific data analysis; Downloadable images in the field of in vitro diagnostics, namely fluorescence images used for in vitro diagnostics; Analyzers for analyzing immunological activity for scientific purposes; Downloadable images in the field of in vitro diagnostics, namely fluorescence images used for in vitro diagnostics

Analyzers for analyzing immunological activity for medical purposes; Analyzers for analyzing immunological activity for medical purposes; Medical apparatus and instrument for diagnostic use, namely, for medical diagnostic testing in the fields of cell-based testing; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for analyzing drug compounds; Immunoassay apparatus for detecting and analyzing biomarkers for medical diagnoses; Medical diagnostic apparatus for testing genomic materials, proteins, and cells relevant to diseases; Medical instruments for analyzing and identifying genomic materials, proteins, and cells; Medical diagnostic apparatus and instruments for detecting and analyzing diseases related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals; Apparatus for medical, clinical, and diagnostic uses by analyzing genomic materials, proteins, and cells related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals; Computer displays and computer monitors and controllers used in direct association with medical diagnosis apparatuses during the process of diagnosis of a condition, namely genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals in an individual; Immunochemical testing apparatus for analyzing genomic materials, proteins, and cells for medical use; Automatic analyzers for disease diagnosis through inspection of genomic materials, proteins, and bio-samples for medical purposes; Apparatus for testing genomic materials, proteins, and cells relevant to diseases for medical purposes; Medical apparatus for testing genomic materials, proteins, and cells relevant to diseases, namely cancer and inflammatory disease; Apparatus for analyzing images for medical use, namely, fluorescence imaging apparatus for medical purpose; Medical diagnostic apparatus for analyzing and measuring genomic materials, proteins, and bio-samples; In vitro medical diagnostic devices for molecularly characterizing diseases related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals